With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Making use of the many readily accessible resources and services available to both physicians and patients can help alleviate awkwardness that may arise when discussing the subject of…
Many important properties and potential health benefits of nicotinamide riboside have been identified since discovery of its role in the human NAD metabolic cycle over a decade ago.
Robotic-arm assisted surgery using the Stryker Mako System may yield better functional results for total hip, as well as for partial or total knee replacement patients due to…
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Nicotinamide riboside appears to be the best precursor supplement available to help maintain or increase NAD+ levels. All cells and tissues can use it, and at high doses…
